Top Story

New recommendations support lower BP target to reduce risk for MI, stroke

April 1, 2015

Patients with hypertension and CAD should be treated to a BP goal of less than 140 mm Hg systolic/90 mm Hg diastolic, according to a scientific statement from the American Heart Association, American College of Cardiology and American Society of Hypertension.

While a target of < 140 mm Hg/90 mm Hg is reasonable to prevent MI and stroke in this patient population, a target of < 130 mm Hg/80 mm Hg may be appropriate in some people with CVD who have had a MI, stroke or transient ischemic attack, or risk equivalents such as peripheral artery disease and abdominal aortic aneurysm, writing committee chair Clive Rosendorff, MD, PhD, DScMed, FAHA, FACC, FASH, and colleagues wrote.

Srihari Naidu Blog

FDA acknowledges high-risk PCI population, gives nod to blood pump system

April 1, 2015
PCI has had its ups and downs, and unfortunately mostly downs in recent years. After the exuberance of the 90s and early 2000s, the field was hit first by concerns…
In the Journals

Diabetes risk higher for middle-aged adults who habitually stay up late

April 1, 2015
Diabetes, metabolic syndrome and sarcopenia were more likely to develop in people who prefer late nights than in early risers, even with the same amount of sleep…
In the Journals

Smoking linked to poor outcomes after revascularization in patients with complex CAD

April 1, 2015
Cigarette smoking was associated with adverse clinical outcomes, including recurrent MI, stroke and death, in patients with complex CAD undergoing revascularization with…
thumbnail for video 4145408164001 Meeting News CoverageVideo

VIDEO: Roxana Mehran, MD, discusses REGULATE-PCI results

March 31, 2015
SAN DIEGO — In this video, Roxana Mehran, MD, professor of medicine at Icahn School of Medicine at Mount Sinai and associate medical editor of Cardiology Today's
More News Headlines »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
Meeting News Coverage Video
thumbnail for video 4143327648001

Researcher looks at relationship between atopic dermatitis, obesity and cardiovascular disease

March 30, 2015
SAN FRANCISCO — In this video, Jonathan I. Silverberg, MD, PhD, MPH, discusses studies examining cardiovascular…
More »
CME
Obesity Consults: Volume 2, Number 1

Obesity Consults: Volume 2, Number 1

This activity is supported by an educational grant from Vivus, Inc.

Obesity is suboptimally managed in clinical practice despite the availability of relevantguidelines and evidence-based…
More »